US Patent 7767697 Factor Xa inhibitors
Patent 7767697 was granted and assigned to Millennium Pharmaceuticals on August, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+472 characters)
Article
Patent abstract
The present invention is directed to compounds of formula (I) and pharmaceutically acceptable salts, esters, and prodrugs thereof which are inhibitors of Factor Xa. The present invention is also directed to intermediates used in making such compounds, pharmaceutical compositions containing such a compound, methods to prevent or treat a number of conditions characterized by undesired thrombosis and methods of inhibiting the coagulation of a blood sample.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Anjali Pandey0
Yonghong Song0
Zhaozhong J. Jia0
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07767697 Factor Xa inhibitors US Patent 7767697 Factor Xa inhibitors
Infobox
Patent Number
077676970
Patent Number
77676970
Edits on 19 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 2 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
077676970
Date of Patent
August 3, 2010
0Patent Application Number
121669440
Date Filed
July 2, 2008
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07767697 Factor Xa inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07767697
Date of patent
August 3, 2010
Patent application number
12166944
Date Filed
July 2, 2008
Patent primary examiner
Find more entities like US Patent 7767697 Factor Xa inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
